2023
DOI: 10.1002/hsr2.1541
|View full text |Cite
|
Sign up to set email alerts
|

Outbreak of severe myocarditis in England: Havoc by a harmless virus

Heeba Anis,
Akbar Basha Shaik,
Angad Tiwari
et al.

Abstract: BackgroundThe World Health Organization (WHO) has been alerted to a concerning upsurge of severe myocarditis, an inflammatory heart condition, in neonates within Wales and South West England. The myocarditis cases are being intricately associated with enterovirus infection, belonging to the Picornaviridae family. The concerned pathogen poses a significant global disease burden, with an estimated 10 to 15 million symptomatic cases occurring annually in the United States alone. Neonates are particularly vulnerab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…EVs can cause a range of diseases, from asymptomatic infections to mild respiratory illness, aseptic meningitis in neonates, acute flaccid paralysis, and death [ 5 ]. Recently, Europe and the US have seen a rise of cases of myocarditis in neonates caused by EVs, including coxsackievirus B3 and B4 [ 6 ]. EV-A71 is responsible for a majority of severe cases and some fatalities in several regions of the world that led to the development of a vaccine in China [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…EVs can cause a range of diseases, from asymptomatic infections to mild respiratory illness, aseptic meningitis in neonates, acute flaccid paralysis, and death [ 5 ]. Recently, Europe and the US have seen a rise of cases of myocarditis in neonates caused by EVs, including coxsackievirus B3 and B4 [ 6 ]. EV-A71 is responsible for a majority of severe cases and some fatalities in several regions of the world that led to the development of a vaccine in China [ 7 ].…”
Section: Introductionmentioning
confidence: 99%